Document Detail


Challenges associated with hypertensive disease during pregnancy in low-income countries.
MedLine Citation:
PMID:  20362990     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the challenges associated with the diagnosis, management, and prevention of hypertensive disease during pregnancy in low-income countries, following the success of the Magpie Trial. METHODS: Descriptive review of the literature from 1990 to 2009 on the diagnosis, management, and prevention of hypertensive disease in pregnancy. RESULTS: In the absence of credible measures to predict and prevent hypertension in pregnancy, diagnosis and treatment remain the only viable options, although they are still associated with important challenges in low-income countries. Despite the presence of high-quality evidence that magnesium sulfate is safe and effective at preventing and treating eclampsia, its use is extremely limited in many low-income countries. CONCLUSION: There is a need for cheap and reliable tools with which to address the diagnostic, preventive, and management challenges associated with hypertensive disease during pregnancy in low-income countries. It is recommended that such countries incorporate magnesium sulfate protocols into their national health and/or practice policies.
Authors:
Kwabena A Danso; Henry S Opare-Addo
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-02
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  110     ISSN:  1879-3479     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-08-04     Completed Date:  2010-11-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  78-81     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Obstetrics and Gynaecology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. kadanso1443@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticonvulsants / adverse effects,  therapeutic use
Antihypertensive Agents / adverse effects,  therapeutic use*
Developing Countries
Eclampsia / drug therapy,  prevention & control
Female
Humans
Hypertension, Pregnancy-Induced / diagnosis,  drug therapy*,  prevention & control
Magnesium Sulfate / adverse effects,  therapeutic use*
Pregnancy
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Antihypertensive Agents; 7487-88-9/Magnesium Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveri...
Next Document:  Factors associated with failure to achieve birth emphasizing a successful singleton at term followin...